Anpario (LON:ANP) Given “House Stock” Rating at Shore Capital

Anpario (LON:ANPGet Free Report)‘s stock had its “house stock” rating restated by Shore Capital in a research note issued to investors on Wednesday,Digital Look reports.

Anpario Price Performance

LON ANP opened at GBX 490.60 on Wednesday. Anpario has a 52 week low of GBX 281.33 and a 52 week high of GBX 498.80. The firm has a market capitalization of £83.14 million, a P/E ratio of 2,009.01 and a beta of 0.58. The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10. The company has a 50-day moving average price of GBX 403.63 and a 200-day moving average price of GBX 412.99.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Recommended Stories

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.